Eric Pujade-Lauraine, MD, PhD

home / authors / eric-pujade-lauraine-md-phd

Articles

Prognostic Factors to Watch Out for in Patients With Ovarian Cancer

May 17th 2022

Eric Pujade-Lauraine, MD, PhD, discusses the prognostic factors researchers are looking for when testing patients with ovarian cancer.

Differences in HRD Testing for Ovarian Cancer Worldwide

Eric Pujade-Lauraine, MD, PhD

March 1st 2022

Eric Pujade-Lauraine, MD, discusses the differences in testing for homologous recombination repair deficiency in patients with ovarian cancer throughout countries.

Exploratory Analyses for JAVELIN Ovarian 200 Demonstrate Potential for Immunotherapy in Select Subgroups

Eric Pujade-Lauraine, MD, PhD

June 12th 2019

Eric Pujade-Lauraine, MD, PhD, discusses the exploratory findings from the phase III JAVELIN Ovarian 200 trial, which investigated the use of combination avelumab plus pegylated liposomal doxorubicin in patients with platinum-resistant, refractory ovarian cancer.